FdaApplication
ANDA 215629
Identifiers
- fda_app_no: ANDA215629
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMAZONE |
| application_type | ANDA |
| approval_date | 2023-06-20 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | 500MG | TABLET, EXTENDED RELEASE;ORAL |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | 1GM | TABLET, EXTENDED RELEASE;ORAL |
2 products